ScreenerHero

MYX Mayne Pharma Group Limited

ASX · AU · Healthcare · Drug Manufacturers - General · maynepharma.com
—Mkt Cap: —P/E: —

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and i…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.12TUSDP/E 40.5
JNJ
Johnson & Johnson
$610.38BUSDP/E 28.7
ABBV
AbbVie Inc.
$500.80BUSDP/E 80.1
RO
Roche Holding AG
$370.64BUSDP/E 25.2
ROP
Roche Holding AG
$364.40BUSDP/E 24.8
MRK
Merck & Co., Inc.
$358.21BUSDP/E 115.2
ROG
Roche Holding AG
$340.19BUSDP/E 22.7
NOVN
Novartis AG
$288.24BUSDP/E 24.0
NVS
Novartis AG
$285.83BUSDP/E 22.0
AZN
AstraZeneca PLC
$260.71BUSDP/E 25.2
AZN
AstraZeneca PLC
$260.59BUSDP/E 26.7
AZN
AstraZeneca PLC
$258.50BUSDP/E 23.9
AMGN
Amgen Inc.
$234.65BUSDP/E 26.1
AZN
AstraZeneca PLC
$260.87BUSDP/E 25.4
GILD
Gilead Sciences, Inc.
$195.13BUSD
NOVO-B
Novo Nordisk A/S
$174.33BUSDP/E 10.1
NVO
Novo Nordisk A/S
$173.08BUSDP/E 9.6
PFE
Pfizer Inc.
$167.80BUSDP/E 38.7
BMY
Bristol-Myers Squibb Company
$123.73BUSDP/E 12.8
GSK
GSK plc
$98.21BUSDP/E 14.9

Key Statistics

Company
Market Cap—
Enterprise Value114.37M USD
Revenue (TTM)265.15M USD
Gross Profit167.77M USD
Net Income (TTM)16.91M USD
Revenue/Share4.80 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees363
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU000000MYX0
Valuation
P/E (Trailing)—
P/E (Forward)-7.77
PEG2.52
EV/EBITDA5.00
EV/Revenue0.43
P/S0.56
P/B0.54
EPS (TTM)0.29
EPS (Forward)-0.34
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin64.16%
Oper. Margin-2.94%
EBITDA Margin8.63%
Profit Margin6.47%
ROE6.26%
ROA2.69%
Growth
Revenue Growth-12.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF9.58M USD
CapEx (TTM)2.29M USD
FCF Margin9.83%
FCF Yield—
Net Debt-25.44M USD
Net Debt/EBITDA-1.11
Balance Sheet
Debt/Equity0.11
Current Ratio1.31
Quick Ratio0.98
Book Value/Sh4.81 AUD
Cash/Share0.98 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 18, 2023
Pay Date—
Splits
Last Split1:20
Split DateJan 18, 2023
Analyst Consensus
Rating—
Target (Mean)4.500 AUD
Target Range3.750 AUD – 5.250 AUD
# Analysts2
Ownership
Shares Out.81.89M
Float44.09M
Insiders22.61%
Institutions24.87%
Technical
SMA 503.008 AUD
SMA 2002.697 AUD
Beta1.02
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)107.96K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—